MERIDIAN
Debt AdvisoryHealthcareCLOSED

Vinci Pharmaceuticals Closes Over $8 Million Series A Financing

Photo via Pexels
Value
$8M
Target
Vinci Pharmaceuticals Inc.

Vinci Pharmaceuticals Inc. has successfully closed a Series A financing round, raising over $8 million to advance its EPIPLANT™ drug delivery platform. Combined with its prior seed funding of $8.5 million, the company has now raised more than $16.5 million.

Read the original at PR Newswire →2026-10-08North America
The Meridian Weekly

The week's largest deals and the Iberian ones, every Monday. Free.

MORE DEALS ON MERIDIAN ->